|HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study|
RK Heaton, DB Clifford, DR Franklin, SP Woods, C Ake, F Vaida, RJ Ellis, ...
Neurology 75 (23), 2087-2096, 2010
|HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors|
RK Heaton, DR Franklin, RJ Ellis, JA McCutchan, SL Letendre, S LeBlanc, ...
Journal of neurovirology 17 (1), 3-16, 2011
|Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system|
S Letendre, J Marquie-Beck, E Capparelli, B Best, D Clifford, AC Collier, ...
Archives of neurology 65 (1), 65-70, 2008
|The HNRC 500-Neuropsychology of HIV infection at different disease stages|
RK Heaton, I Grant, N Butters, DA White, D Kirson, JH Atkinson, ...
Journal of the International Neuropsychological Society 1 (3), 231-251, 1995
|The prevalence and incidence of neurocognitive impairment in the HAART era|
KR Robertson, M Smurzynski, TD Parsons, K Wu, RJ Bosch, J Wu, ...
Aids 21 (14), 1915-1921, 2007
|Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV|
RJ Ellis, JM Olichney, LJ Thal, SS Mirra, JC Morris, D Beekly, A Heyman
Neurology 46 (6), 1592-1596, 1996
|Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial|
RJ Ellis, W Toperoff, F Vaida, G Van Den Brande, J Gonzales, B Gouaux, ...
Neuropsychopharmacology 34 (3), 672, 2009
|Dendritic injury is a pathological substrate for human immunodeficiency virus—related cognitive disorders|
E Masliah, RJ Ellis, M Mallory, RK Heaton, TD Marcotte, JA Nelson, ...
Annals of Neurology: Official Journal of the American Neurological …, 1997
|HIV and antiretroviral therapy in the brain: neuronal injury and repair|
R Ellis, D Langford, E Masliah
Nature Reviews Neuroscience 8 (1), 33, 2007
|Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome|
RJ Ellis, K Hsia, SA Spector, JA Nelson, RK Heaton, MR Wallace, ...
Annals of neurology 42 (5), 679-688, 1997
|Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance|
CM Marra, Y Zhao, DB Clifford, S Letendre, S Evans, K Henry, RJ Ellis, ...
AIDS (London, England) 23 (11), 1359, 2009
|CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy|
RJ Ellis, J Badiee, F Vaida, S Letendre, RK Heaton, D Clifford, AC Collier, ...
AIDS (London, England) 25 (14), 2011
|Dementia and neurocognitive disorders due to HIV-1 infection|
BM Ances, RJ Ellis
Seminars in neurology 27 (01), 086-092, 2007
|Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder|
IP Everall, RK Heaton, TD Marcotte, RJ Ellis, JA McCutchan, JH Atkinson, ...
Brain Pathology 9 (2), 209-217, 1999
|Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy|
LA Cysique, F Vaida, S Letendre, S Gibson, M Cherner, SP Woods, ...
Neurology 73 (5), 342-348, 2009
|Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy|
TH Burdo, MR Lentz, P Autissier, A Krishnan, E Halpern, S Letendre, ...
Journal of Infectious Diseases 204 (1), 154-163, 2011
|Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders|
SL Letendre, JA McCutchan, ME Childers, SP Woods, D Lazzaretto, ...
Annals of neurology 56 (3), 416-423, 2004
|Effects of methamphetamine dependence and HIV infection on cerebral morphology|
TL Jernigan, AC Gamst, SL Archibald, C Fennema-Notestine, MR Mindt, ...
American Journal of Psychiatry 162 (8), 1461-1472, 2005
|A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection|
K Kieburtz, D Simpson, C Yiannoutsos, MB Max, CD Hall, RJ Ellis, ...
Neurology 51 (6), 1682-1688, 1998
|Neurocognitive impairment is an independent risk factor for death in HIV infection|
RJ Ellis, R Deutsch, RK Heaton, TD Marcotte, JA McCutchan, JA Nelson, ...
Archives of neurology 54 (4), 416-424, 1997